About Genedrive
Genedrive is a company based in Manchester (United Kingdom) founded in 2000 by Christopher Potten and Catherine Booth.. Genedrive offers products and services including Genedrive System, Genedrive MT-RNR1 ID Kit, and Genedrive CYP2C19 ID Kit. Genedrive operates in a competitive market with competitors including Prenetics, Inflammatix, Karius, Day Zero Diagnostics and MeMed, among others.
- Headquarter Manchester, United Kingdom
- Founders Christopher Potten, Catherine Booth
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Genedrive Plc
-
Annual Revenue
$627.72 K (USD)810.91as on Jun 30, 2024
-
Net Profit
$-8.87 M (USD)-37.38as on Jun 30, 2024
-
EBITDA
$-6.35 M (USD)-1.91as on Jun 30, 2024
-
Latest Funding Round
$1.59 M (USD), Post-IPO
Apr 01, 2025
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Genedrive
Genedrive is a publicly listed company on the LSE with ticker symbol GDR in UK, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Genedrive
Genedrive offers a comprehensive portfolio of products and services, including Genedrive System, Genedrive MT-RNR1 ID Kit, and Genedrive CYP2C19 ID Kit. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for rapid molecular testing of pathogens and variants
Test to detect gene variant preventing antibiotic-induced hearing loss
Rapid test for CYP2C19 genotyping to inform treatment decisions
Unlock access to complete
Funding Insights of Genedrive
- Total Funding Total Funding
- Total Rounds 2
- Last Round Post-IPO — $1.6M
-
First Round
First Round
(22 Nov 2018)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2025 | Amount | Post-IPO - Genedrive | Valuation |
investors |
|
| Nov, 2018 | Amount | Post-IPO - Genedrive | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Genedrive
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Genedrive
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Genedrive Comparisons
Competitors of Genedrive
Genedrive operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prenetics, Inflammatix, Karius, Day Zero Diagnostics and MeMed, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
|
| domain | founded_year | HQ Location |
Provider of diagnostic solutions for systemic infections
|
|
| domain | founded_year | HQ Location |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| domain | founded_year | HQ Location |
Genome sequencing diagnostics for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| domain | founded_year | HQ Location |
Portable PCR diagnostics for infectious diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Genedrive
Frequently Asked Questions about Genedrive
When was Genedrive founded?
Genedrive was founded in 2000 and raised its 1st funding round 18 years after it was founded.
Where is Genedrive located?
Genedrive is headquartered in Manchester, United Kingdom. It is registered at Manchester, Greater Manchester, United Kingdom.
Who is the current CEO of Genedrive?
James Cheek is the current CEO of Genedrive.
What is the annual revenue of Genedrive?
Annual revenue of Genedrive is $627.72K as on Jun 30, 2024.
What does Genedrive do?
Genedrive was established in 2000 in Manchester, United Kingdom, within the molecular diagnostics sector. A platform for point-of-care genotyping and sequence analysis is operated, focusing on pharmacogenetic and infectious disease screening. The MT-RNR1 ID Kit is supplied as a test to identify risks of antibiotic-induced deafness in infants. The Genedrive HCV ID Kit is utilized for hepatitis C detection and COVID-19 screening in clinical settings.
Who are the top competitors of Genedrive?
Genedrive's top competitors include Visby Medical, Inflammatix and Prenetics.
What products or services does Genedrive offer?
Genedrive offers Genedrive System, Genedrive MT-RNR1 ID Kit, and Genedrive CYP2C19 ID Kit.
Is Genedrive publicly traded?
Yes, Genedrive is publicly traded on LSE under the ticker symbol GDR.
What is Genedrive's ticker symbol?
The ticker symbol of Genedrive is GDR on LSE.